Skip to content 
The research on EBOO therapy for chronic fatigue is promising but limited. In a 2021 Italian study of 200 patients with myalgic encephalomyelitis (also called chronic fatigue syndrome or ME/CFS), 70 to 77 percent reported significant improvement in fatigue, with no side effects and benefits lasting through a three-month follow-up. One honest caveat matters: that study used oxygen-ozone autohemotherapy, a related ozone method, not EBOO specifically. There are still no large-scale randomized controlled trials of EBOO for chronic fatigue, and it is not a proven cure. EBOO is not FDA-approved.
That is the honest headline. If you are new to the treatment, our guide to EBOO therapy explains the basics. This article focuses on the fatigue question: what the research actually found, why researchers think ozone might help, the gap between the studied therapy and EBOO, and how to think realistically about EBOO therapy for chronic fatigue if you are living with it.
Chronic fatigue syndrome is a real, often debilitating condition, and people living with it deserve straight information rather than hype. Here is what the strongest available research on EBOO therapy for chronic fatigue actually found.
The most cited work comes from an Italian research group led by Tirelli. In a 2021 study of 200 patients with ME/CFS, researchers treated patients with oxygen-ozone autohemotherapy and measured fatigue with the Fatigue Severity Scale before and after. Between 70 and 77.5 percent of patients showed a significant improvement in their fatigue symptoms. No patients reported side effects, and the improvement remained at the three-month follow-up. An earlier study from the same group in 65 patients, and follow-up work in 100 patients, pointed in the same direction.
Those results are genuinely encouraging, and it would be dishonest to dismiss them. It would be equally dishonest to oversell them, so here is the other half of the picture that most clinic pages leave out.
Before you read EBOO as a solved answer for chronic fatigue, three things need to be clear, and most clinic pages will not tell you any of them.
This is the distinction almost every website blurs. The strongest fatigue research used oxygen-ozone autohemotherapy, a method where a quantity of blood is mixed with the gas and returned. EBOO is a related but different, higher-volume extracorporeal method. It is reasonable to think the underlying ozone mechanism may carry over, but strictly speaking the studies are on the related therapy, not on EBOO itself. Any page citing these numbers as proof for EBOO specifically is taking a shortcut with the truth.
The existing studies, while encouraging, largely come from one research group, and the field lacks the large, randomized, placebo-controlled trials needed to consider this established. Even the AI-generated summaries you may have seen flag this. Promising early evidence warrants cautious interest, not certainty.
Chronic fatigue syndrome has no known cure, and ozone therapy is not one. At best, the research suggests it may help some people manage fatigue symptoms. Anyone presenting EBOO therapy for chronic fatigue as a cure, or as a replacement for the rest of your medical care, is not being straight with you.
If the results are real, why would ozone affect fatigue at all? Researchers point to a few proposed mechanisms. It is worth stressing the word proposed, because these are working theories, not confirmed facts.
The first idea centers on cellular oxygen use. Fatigue in ME/CFS is linked to problems with how cells produce energy, and ozone therapy is proposed to improve how efficiently cells take up and use oxygen. The second focuses on the mitochondria, the energy factories inside your cells, which are a major target in fatigue research; ozone is theorized to support their function. The third is inflammation. Chronic inflammation is one factor associated with ME/CFS, and ozone may help modulate inflammatory signals. Each of these is a plausible, research-backed hypothesis, and none is a settled mechanism. An honest clinician tells you that.
In the studies, oxygen-ozone therapy was well tolerated, and no participants reported side effects. That is reassuring, but safety always depends on the individual, which is why screening comes first. If you are considering this, it is worth reading honestly about whether EBOO therapy is safe in general and understanding the common EBOO side effects so you know what a normal response looks like. Screening matters for everyone, and some people are not candidates at all, so check who should not have EBOO before you pursue it. Chronic fatigue often comes with other conditions and medications, which makes that screening step especially important.
There is no established session count for chronic fatigue specifically. Research protocols use repeated sessions over weeks, but a study protocol is not a personal prescription. In practice, your provider sets the number of sessions based on your situation and response, and our overview explains how that is usually decided. Cost naturally follows from the session count, so if you are planning practically, our breakdown of what EBOO therapy costs will help you budget for a realistic course rather than a single visit.
Whether to try EBOO therapy for chronic fatigue is a decision for you and a provider who knows your full medical history, not something a web page can answer.
Chronic fatigue is one of the most frustrating conditions I see, precisely because patients have so often been dismissed or offered very little. That is exactly why I refuse to oversell EBOO therapy for chronic fatigue. The early research genuinely interests me, and I have seen people feel better. But I will always tell someone with chronic fatigue the truth: this is a promising option to explore thoughtfully, not a cure I can promise. Hope built on honesty lasts longer than hope built on a sales pitch.
Early research is promising. A 2021 study found 70 to 77 percent of ME/CFS patients had significant fatigue improvement after oxygen-ozone therapy. However, that study used a related ozone method rather than EBOO specifically, and no large-scale trials of EBOO therapy for chronic fatigue exist, so it is not proven.
The strongest studies, from an Italian research group, reported significant fatigue improvement in most ME/CFS patients treated with oxygen-ozone autohemotherapy, with no side effects and benefits lasting up to three months. The evidence is encouraging but comes largely from one group and lacks large randomized controlled trials.
No. Chronic fatigue syndrome has no known cure, and EBOO is not one. At best, current research suggests ozone therapy may help some people manage fatigue symptoms. Consider it alongside standard medical care, not as a replacement.
The proposed mechanisms include improving cellular oxygen use, supporting mitochondrial function, and lowering inflammation, all of which are linked to fatigue. These are working theories from the research, not confirmed facts.
There is no established number for chronic fatigue specifically. Research protocols used repeated sessions over weeks, but a provider should set your plan based on your situation, not a study.
Purefico in Cornelius, NC, near Charlotte, offers EBOO with honest guidance about what the research does and does not show for chronic fatigue, plus full screening before any treatment.
Melissa Lynch, NP, is a nurse practitioner with 28 years of clinical experience and the founder of Purefico MedSpa & Therapy, with locations in Cornelius and Archdale, North Carolina.
